The GlaxoSmithKline Payroll Part II

Judith A. Aberg, M.D., Director of HIV Services, Washington University, St. Louis, MO. Received funding for clinical research from Abbott Laboratories and Agouron; serves on the speakers bureau for Merck and Fujisawa (now Astellas Pharma US). (http://www.thebodypro.com/bios/jaberg.html, accessed 1/24/07) Received grants for educational activities from and/or served as an advisor or consultant to Abbott, Bristol-Myers Squibb, Boehringer Ingelheim, Gilead, GlaxoSmithKline, and Roche. (http://www.medscape.com/viewarticle/513050, accessed 1/24/07)

----

Martin J. Abrahamson, M.D., Associate Professor, Harvard Medical School, Boston, MA. Acting Chief Medical Officer, Joslin Diabetes Center, Boston, MA. Receives research grants from Pfizer Inc.; member of the speaker's bureaus for AstraZeneca Pharmaceuticals LP, Aventis Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Merck & Co., Novo Nordisk, Novartis, Pfizer Inc, and Takeda Pharmaceuticals North America. (http://www.medscape.com/viewprogram/3942_authors; accessed 7/28/05)

----

Kirkwood F. Adams, M.D., Associate Professor of Medicine and Radiology, University of North Carolina, Chapel Hill, NC. Received research support from Actelion Pharmaceuticals U.S., Inc., Amgen, Inc., AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb, GlaxoSmithKline, Myogen, Inc., Novartis Pharmaceuticals Corporation, NitroMed, Inc., NovaCardia, Inc., Otsuka America Pharmaceutical, Inc., Scios Inc., and Vasogen Inc. Consultant to Abbott Laboratories, Amgen, Inc., AstraZeneca Pharmaceuticals LP, Biosite, Inc., Bristol-Myers Squibb, GlaxoSmithKline, Myogen, Inc., Otsuka America Pharmaceutical, Inc., Pfizer Inc., Sanofi-Synthelabo Inc., and Scios Inc. (http://www.medscape.com/viewprogram/4088_authors; accessed 7/28/05)

----

Jasjit S. Ahluwalia, M.D., M.P.H., Professor of Preventive Medicine and Public Health and Professor of Internal Medicine, University of Kansas, Kansas City. Served as consultant to GlaxoSmithKline. (Evans, Jeff. Sustained-Release bupropion boosts smoking cessation in African Americans, Family Practice News, 1/1/03, p.12)
EMAIL
----

Hagop S. Akiskal, M.D., Professor of Psychiatry, Director of the International Mood Center, University of California at San Diego, La Jolla. Received grant or research support from Eli Lilly. Served as a consultant to Abbott, Janssen Pharmaceutica, and Eli Lilly. Served on the speakers’ bureaus of Abbott, GlaxoSmithKline, Janssen Pharmaceutica, and Eli Lilly. (http://www.wpic.pitt.edu/STANLEY/5thbipconf/introduction.htm; accessed 5/27/05)
EMAIL
----

George S. Alexopoulos, M.D., Professor of Psychiatry at Weill Medical College, Cornell University, Ithaca, NY. Receives honoraria from Cephalon. (http://www.psychiatrist.com/audiograph/stahl/indexc.htm; accessed 3/4/04) Receives grant/research support from Forest Laboratories and Cephalon; consultant to Forest Laboratories; and member of the speakers bureau for Forest Laboratories, Eli Lilly, Pfizer, GlaxoSmithKline, and Janssen. (Conference disclosure notes; 41st Annual Meeting of the American College of Neuropsychopharmacology, December 2002, San Juan, Puerto Rico; on file with CSPI)
EMAIL
----

Lori Altshuler, M.D., Professor and Director, Mood Disorders Research Program, University of California, Los Angeles. Grants/research support from Abbott Laboratories, Eli Lilly, Forest Labs, Glaxo-Wellcome, SmithKlineBeecham, and Solvay. Consultant to Abbott Laboratories, Eli Lilly, Forest Labs, Janssen, Parke Davis, and Bristol Myers Squibb. Member,speakers bureaus of Abbott Laboratories, Eli Lilly, Glaxo-Wellcome, and Solvay. Scientfic Advisory Board for Abbott Laboratories, Eli Lilly, and Forest Labs. (Conference disclosure notes: 41st Annual Meeting of the American College of Neuropsychopharmacology, December 2002, San Juan, Puerto Rico; on file with CSPI; Primary Care Companion J Clin Psychiatry. 2000; 2:217-23)

----

Jean Anderson, M.D., Professor, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD. Serves on the advisory board, speakers bureau, receives research support from, and holds stock in Pfizer; received honoraria from GlaxoSmithKline and Abbott Laboratories; receives educational program support from GlaxoSmithKline, Abbott Laboratories, Boehringer Ingelheim, and Pfizer. (http://www.guideline.gov/summary/summary.aspx?doc_id=9868, accessed 1/26/07)

----

Janet B. Arrowsmith-Lowe, M.D., F.A.C.P., Partner, Arrowsmith-Lowe Consulting. Works for a consulting company whose clients include Bayer, GlaxoSmithKline, Merck, Pfizer, and Wyeth. (http://www.fda.gov/ohrms/dockets/ac/05/transcripts/2005-4090T2.htm; accessed 7/8/05)
EMAIL
----

Michael E. Aulton, B.Pharm., Ph.D., M.R.Pharm.S., Professor of Pharmaceutical Technology and Head of Graduate School, De Montfort University, Bedford, UK. Patent advice consultancy with Pfizer from Jan. to Feb. 2002. Receives research grant funding from GlaxoSmithKline, R.P. Scherer, Pfizer and AstraZeneca. (http://www.mca.gov.uk/aboutagency/regframework/csm/csmdoi01.pdf; accessed 7/18/03)




Part I HERE

Source:- Integrity in Science